Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10591491 | Bioorganic & Medicinal Chemistry Letters | 2013 | 9 Pages |
Abstract
We describe the structure-based design of a novel lead chemotype that binds to thumb pocket 2 of HCV NS5B polymerase and inhibits cell-based gt1 subgenomic reporter replicons at sub-micromolar concentrations (EC50Â <200Â nM). This new class of potent thumb pocket 2 inhibitors features a 1H-quinazolin-4-one scaffold derived from hybridization of a previously reported, low affinity thiazolone chemotype with our recently described anthranilic acid series. Guided by X-ray structural information, a key NS5B-ligand interaction involving the carboxylate group of anthranilic acid based inhibitors was replaced by a neutral two-point hydrogen bonding interaction between the quinazolinone scaffold and the protein backbone. The in vitro ADME and in vivo rat PK profile of representative analogs are also presented and provide areas for future optimization of this new class of HCV polymerase inhibitors.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Pierre L. Beaulieu, René Coulombe, Jianmin Duan, Gulrez Fazal, Cédrickx Godbout, Oliver Hucke, Araz Jakalian, Marc-André Joly, Olivier Lepage, Montse Llinà s-Brunet, Julie Naud, Martin Poirier, Nathalie Rioux, Bounkham Thavonekham, George Kukolj,